FAM122A inhibition of PP2A-B55 through a bipartite binding mechanism

This study reveals that FAM122A inhibits PP2A-B55 through a bipartite binding mechanism involving both N-terminal helices and a novel C-terminal region (residues 150–170), where phosphorylation of the conserved Ser158 residue regulates this interaction to control cell cycle progression.

The Gist

The Big Picture: A Cellular Traffic Cop

Imagine your cell is a busy city. To keep things running smoothly, the city needs to switch between "day mode" (growing and resting) and "night mode" (dividing and making new buildings). This switch is controlled by a team of traffic cops.

One of the most important cops is a protein called PP2A-B55. Its job is to hit the brakes on cell division. It stops the city from dividing too early. If this cop is too active, the city never grows. If the cop is too lazy, the city falls into chaos.

To divide properly, the cell needs to temporarily fire this cop. It does this by sending in "inhibitors"—little proteins that handcuff the cop so it can't do its job. One of these inhibitors is a protein called FAM122A.

The Mystery: How Does the Handcuff Work?

Scientists already knew that FAM122A acts as a handcuff for PP2A-B55. They even had a "blueprint" (a 3D structure) showing that the front part of FAM122A (the N-terminus) has two helical arms that grab onto the cop.

But there was a missing piece of the puzzle: How does the cell know when to use FAM122A? Is the handcuff always on, or does the cell turn it on and off like a light switch?

The Discovery: It's a Two-Handed Grip

The researchers in this paper decided to look at the entire FAM122A protein, not just the front part. They found something surprising:

1. The Front Hand: The N-terminal helices (the front part) grab the cop.
2. The Back Hand: They discovered a new, hidden region at the very back of the protein (residues 150–170) that is also required to hold on tight.

The Analogy: Imagine trying to hold a slippery barbell. If you only use one hand, it slips right out. But if you use both hands—one at the front and one at the back—you have a secure, "bipartite" (two-part) grip. FAM122A needs both ends to effectively handcuff the PP2A-B55 cop.

The Secret Switch: The "Ser158" Button

Inside that "back hand" region, there is a specific amino acid called Serine-158 (Ser158). Think of this as a molecular button.

• The Button is Unpressed: When Ser158 is just a normal amino acid, FAM122A can still grab the cop, but not very well.
• The Button is Pressed (Phosphorylated): The cell can add a tiny chemical tag (a phosphate group) to this button. The researchers found that when this button is pressed, FAM122A becomes a super-effective inhibitor.

The Timing: The researchers checked when this button gets pressed. They found that it happens right when the cell is about to divide (during mitosis). This suggests the cell has a built-in timer: "Okay, it's time to divide. Press the Ser158 button on FAM122A so it can handcuff the brakes and let the cell split."

The Experiment: Testing the Theory

To prove this, the scientists did two main things:

1. In Human Cells: They created a version of FAM122A where the "button" (Ser158) was broken (mutated). Without this button, FAM122A couldn't bind to the cop effectively, and the cell couldn't stop the brakes from working. The cell division process got stuck.
2. In Frog Eggs: They used frog eggs (a classic model for studying cell division) to watch the process in real-time. When they added normal FAM122A, the cells divided quickly. When they added the "broken button" version, the cells were 30 minutes late to the party. They couldn't start dividing on time.

Why Does This Matter?

This paper solves a major mystery in cell biology. It explains how FAM122A works (it needs a two-handed grip) and how it is regulated (a chemical switch at Ser158).

The Takeaway:
Think of cell division like a race car.

• PP2A-B55 is the brake pedal.
• FAM122A is the driver's foot pressing the brake to stop the car.
• Ser158 is the gas pedal that tells the driver when to let go of the brake and hit the gas.

If the driver (FAM122A) doesn't have the gas pedal (Ser158) working, the car (the cell) can't accelerate into the next phase of the race. This research shows us exactly how that gas pedal is connected and why it's essential for life.

Technical Summary

1. Problem Statement

The Ser/Thr phosphatase PP2A-B55 is a critical regulator of the cell cycle, acting as an antagonist to Cyclin-Dependent Kinases (CDKs). For mitotic entry to occur, PP2A-B55 activity must be transiently inhibited. While the mechanisms for two known inhibitors, ARPP19 and ENSA, are well-characterized (relying on phosphorylation by the Greatwall kinase to bind the catalytic site), the regulation of the third inhibitor, FAM122A, remains unclear.

Although recent cryo-EM structures revealed that the N-terminal helices of FAM122A bind PP2A-B55, it is unknown:

1. Whether the full-length protein requires additional domains for efficient binding in a cellular context.
2. Whether FAM122A's inhibitory activity is regulated by phosphorylation during the cell cycle, similar to ARPP19/ENSA.

2. Methodology

The authors employed a multi-system approach combining cell biology, structural modeling, and biochemistry:

• Cell Line Engineering:
  • Generated a FAM122A knockout (KO) U2OS cell line using CRISPR-Cas9.
  • Created stable inducible cell lines (U2OS Flp-In T-REx) to re-express Wild-Type (WT) and mutant FAM122A variants.
  • Used HeLa cells for transient transfection experiments.
• Functional Assays:
  • Phosphatase Activity Assay: Measured PP2A-B55 activity in immunopurified complexes using a model peptide substrate.
  • Okadaic Acid (OA) Sensitivity: Tested cell survival in KO vs. WT lines to infer changes in cellular phosphatase activity.
  • Colony Formation Assays: Quantified cell survival under OA stress.
  • Cell Cycle Synchronization: Used double thymidine release to analyze FAM122A-PP2A interactions across S-phase to M-phase.
• Structural & Binding Analysis:
  • Truncation & Alanine Scans: Systematically deleted regions of FAM122A and performed single-residue alanine scans (specifically in the C-terminal region) to map binding determinants.
  • Co-Immunoprecipitation (IP): Used YFP/GFP-trap pull-downs followed by Western blotting to assess binding to PP2A subunits (C, B55, A).
  • Mass Spectrometry (MS):
    • IP-MS: Quantified PP2A subunit co-purification with FAM122A mutants.
    • Phosphoproteomics: Analyzed phosphorylation occupancy of FAM122A in asynchronous vs. mitotic cells.
  • AlphaFold 3 Modeling: Generated structural models of full-length FAM122A bound to PP2A-B55, including phosphorylated Ser158.
• Xenopus laevis Egg Extracts:
  • Used interphase extracts to test the ability of recombinant human FAM122A (WT vs. S158A) to stimulate mitotic entry, monitored via Western blotting of cell cycle markers (Cyclin B2, Cdk1-Y15, Greatwall).
• Antibody Generation: Produced a custom phospho-specific antibody against FAM122A-Ser158.

3. Key Contributions & Results

A. Discovery of a Bipartite Binding Mechanism

• N-terminal Helices: Confirmed that the N-terminal helices (residues 81–111) bind the B55 substrate pocket and the catalytic subunit, consistent with previous cryo-EM data.
• C-terminal Requirement: Surprisingly, truncation mutants lacking the C-terminus (specifically residues 150–170) failed to bind PP2A-B55 efficiently in cells, despite retaining the N-terminal helices.
• Alanine Scan: A single alanine scan of the 150–170 region identified that residues 154–159 are critical for binding.
• Conclusion: Efficient binding requires a bipartite mechanism involving both the N-terminal helices and the C-terminal region (150–170).

B. Identification of Ser158 as a Critical Regulator

• Ser158 Importance: Within the critical 154–159 region lies Ser158, a conserved residue with a proline-directed kinase consensus sequence.
• Loss of Function: The S158A mutation completely abolished binding to all PP2A-B55 isoforms in cells and prevented the inhibition of PP2A-B55 phosphatase activity.
• Phosphorylation Dynamics:
  • MS analysis showed increased phosphorylation occupancy at Ser158 during mitosis compared to asynchronous cells.
  • In Xenopus egg extracts, recombinant WT FAM122A promoted rapid mitotic entry, whereas the S158A mutant caused a significant 30-minute delay in mitotic entry markers (Gwl hyperphosphorylation, Cyclin B2 degradation).
  • A phospho-specific antibody confirmed rapid phosphorylation of Ser158 upon mitotic entry in Xenopus extracts.

C. Structural Modeling of Regulation

• AlphaFold 3 Predictions: Modeling of the phosphorylated S158 (pS158) variant suggested that the phosphate group could directly occupy the active site of the PP2A catalytic subunit (PPP2CA), mimicking the mechanism of ARPP19/ENSA.
• Phosphomimetic Failure: Mutations to Glutamate (S158E) or Threonine (S158T) also failed to bind PP2A-B55. The authors suggest this is likely because Glu is not a true phosphomimetic in this context, or Thr is rapidly dephosphorylated by PP2A-B55 itself.

4. Significance

• Novel Regulatory Mechanism: This study establishes that FAM122A inhibition of PP2A-B55 is not static but likely regulated by phosphorylation at Ser158, which correlates with the cell cycle stage requiring PP2A-B55 inhibition (mitosis).
• Bipartite Binding: It redefines the structural requirements for FAM122A-PP2A interaction, showing that the C-terminal unstructured region is essential for high-affinity binding, working in concert with the N-terminal helices.
• Functional Conservation: The data suggests a convergent evolutionary strategy where FAM122A, like ARPP19 and ENSA, utilizes a phosphorylation-dependent mechanism to inhibit PP2A-B55, potentially via direct competition for the catalytic active site.
• Therapeutic Implications: Understanding how FAM122A is regulated provides new insights into cell cycle control and the response to Chk1 inhibition, which is relevant for cancer therapy strategies targeting phosphatase activity.

5. Conclusion

The authors conclude that FAM122A inhibits PP2A-B55 through a bipartite binding mechanism involving N-terminal helices and a C-terminal region (150–170). Crucially, the phosphorylation of Ser158 within this C-terminal region is essential for efficient binding and inhibition, suggesting that FAM122A activity is dynamically regulated during the cell cycle to ensure timely mitotic entry.